BridgeMD
New treatment option for Methamphetamine Use Disorder
Official title Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder
ClinicalTrials.gov ID: NCT06457230
What this study is testing
- What it's testing
- To investigate the mechanism and efficacy of a novel repetitive transcranial magnetic stimulation (rTMS) intervention model with paired cerebellar-medial prefrontal cortex (mPFC) pulses on methamphetamine use disorder patients and to develop a novel physiotherapeutic intervention to optimise the treatment and management.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60, men only. Healthy volunteers may be eligible.
You may be able to join if
- Participants will be eligible for inclusion if they meet the following criteria:
- Methamphetamine is the primary substance of use, and the participant meets the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition...
- aged 18 to 60 years;
- normal or corrected-to-normal vision and hearing, and right-handedness;
- primary school education or above, with the ability to understand the questionnaires and behavioral task instructions.
You likely can't join if
- Participants will be excluded if they meet any of the following criteria:
- presence of metal objects in the body, such as metal dentures, orthodontic braces, bone fixation plates, aneurysm clips, or other metallic implants;
- severe physical illness or chronic disease, including heart disease, severe hypertension, stroke, epilepsy, or history of head trauma;
- comorbid psychiatric disorders, such as bipolar disorder, schizophrenia, or severe depression;
- previous participation in transcranial magnetic stimulation- or electroencephalography-related studies;
- refusal to participate in the study, poor compliance, or any other contraindications to transcranial magnetic stimulation.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.